# KWF Lead4Life PPP 2026

**Funder:** KWF
**Budget:** €5,000,000 total
**Deadline:** 9 September 2026 (Lead-212 radiopharmaceuticals PPP)
**Duration:** Up to 4 years
**Consortium:** Required — PPP
**Application:** Single stage
**TRL:** Applied / industrial
**Frequency:** One-off
**Official call:** https://www.kwf.nl/en/forresearchers/funding/lead4life
**Last updated:** 4 Jul 2026

> **Recently updated:** catalog cleanup 2026-07-04: duplicate row (canonical sibling kept)

## Summary

The KWF Lead4Life PPP funds cancer research partnerships combining academic and industry expertise to develop Lead-212 radiopharmaceuticals, with grants of €300,000-€1,500,000 per consortium over up to four years. This is a one-off call from KWF structured as a public, private partnership, targeting applied and translational projects ready to move toward clinical use. Consortia must include at least one commercial partner; academic groups and clinicians are encouraged to team with industry to advance patient-ready tools.

## Who should apply

- Academic cancer researchers with Lead-212 radiopharmaceutical projects ready for translation
- Consortia including at least one industry or SME partner (mandatory for PPP)
- Clinical teams with nuclear medicine, oncology, or molecular imaging expertise
- Research groups based at Dutch academic or hospital institutions
- Projects at applied TRL (6-8) with a clear pathway to patient benefit

## Key dates

- Deadline: 9 September 2026
- Single-stage application
- Up to four-year project duration

## Tips for applicants

- Industry partnership strength is decisive in PPP evaluation, secure a named, committed co-applicant from a pharmaceutical, biotech, or diagnostic company before submission.
- Lead-212 specificity is essential; proposals on other alpha-emitters or broad radiopharmaceutical platforms will not fit this call.
- Include a translational roadmap with regulatory milestones (e.g. GMP manufacturing plan, IND timeline); KWF expects clinical-phase pathway, not proof-of-concept.

## Frequently asked questions

### What is the budget for the KWF Lead4Life PPP?

Grants range from €300,000 to €1,500,000 per consortium over the project duration.

### Do I need a company partner to apply for the KWF Lead4Life PPP?

Yes, this is a public, private partnership call; consortia must include at least one industry, SME, or commercial partner.

### How long is the KWF Lead4Life PPP project?

Projects run for up to four years from award.

### Is this a one-time call?

Yes, the KWF Lead4Life PPP is a one-off call with a single deadline in 2026; there is no indication of future rounds.

### What is the focus of the KWF Lead4Life PPP?

The call funds development of Lead-212 radiopharmaceuticals for cancer treatment, targeting projects at applied and translational technology readiness levels.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-lead4life-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=kwf-lead4life-2026).